Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

52.11 -0.85 (-1.60%)

Streaming Delayed Price Updated: 11:52 AM EDT, Aug 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

45 46 Next >

Why Roche's Flop In Lung Cancer Hammered Arcus, Iteos And Others ↗

May 11, 2022

Roche isn't the only company working on an anti-TIGIT molecule.

Via Investor's Business Daily

Dividend Income Update April 2022 ↗

May 10, 2022

With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated.

Via Talk Markets

GlaxoSmithKline Clocks 32% Topline Growth Buoyed By COVID-19 Therapy, Shingrix Vaccine ↗

April 27, 2022

Via Benzinga

Recap: GlaxoSmithKline Q1 Earnings ↗

April 27, 2022

GlaxoSmithKline (NYSE:GSK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Germany Inks COVID-19 Vaccine Deal With CureVac, GSK Until 2029 ↗

April 11, 2022

Via Benzinga

Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)

April 11, 2022

Via Investor Brand Network

GlaxoSmithKline's Earnings Outlook ↗

April 26, 2022

GlaxoSmithKline (NYSE:GSK) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Public-health Authorities in US, UK, Probe Mysterious Cases Of Severe Hepatitis In Young Kids: WSJ ↗

April 22, 2022

Via Benzinga

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data ↗

April 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance ↗

April 21, 2022

Via Benzinga

4 Undervalued Biotech Stocks to Add to Your Buy List ↗

April 20, 2022

These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.

Via InvestorPlace

Watch for Continued Gains in Shares of GlaxoSmithKline PLC (GSK)

April 11, 2022

Via Investor Brand Network

Why Did FDA Pull Authorization For GSK-Vir's COVID-19 Therapy? Read Here ↗

April 06, 2022

Via Benzinga

As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ ↗

April 18, 2022

In the latest phase of the COVID-19 pandemic, federal and local officials are leaving it up to people to assess if they need booster shots, whether to wear a mask and how long to isolate after a...

Via Benzinga

The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More ↗

April 17, 2022

Biotech stocks retreated in the week ending April 14, lock-stepping with the broader market. The news flow was light during the holiday-shortened week and ahead of the imminent first-quarter reporting...

Via Benzinga

Why Is Sierra Oncology (SRRA) Stock Up Today? ↗

April 13, 2022

Late-phase cancer treatment company Sierra Oncology is up big today after being acquired by GlaxoSmithKline. SRRA stock is soaring.

Via InvestorPlace

Sierra Oncology Stock Is Soaring: Here's Why ↗

April 13, 2022

Sierra Oncology Inc (NASDAQ: SRRA) shares are trading significantly higher Wednesday after the company announced it will be acquired by GlaxoSmithKline PLC (NYSE: GSK) for $55 per share in...

Via Benzinga

CureVac - GSK Start Dosing In Next-Gen COVID-19 Vaccine Candidate Trial ↗

March 30, 2022

Via Benzinga

Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares ↗

April 13, 2022

GlaxoSmithKline said Wednesday it will buy Sierra Oncology for $1.9 billion, sending the biotech stock flying.

Via Investor's Business Daily

The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More ↗

April 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal

Via Benzinga

GlaxoSmithKline Scoops Up Rare Cancer-Focused Sierra Oncology In $1.9B Cash Deal ↗

April 13, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 13, 2022

Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Watch For Continued Gains In Shares Of GlaxoSmithKline PLC (GSK) ↗

April 11, 2022

This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.

Via Benzinga

Highly Rated GlaxoSmithKline Eyes Breakout After Racking Up Series Of Wins ↗

April 11, 2022

The move comes after the FDA shut down its Vir-partnered Covid antibody, however.

Via Investor's Business Daily

What Is RSV, And Why Is Pfizer Paying Up To $525M For Treatment Candidates? ↗

April 07, 2022

Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.

Via Benzinga

New Large-Scale Observational Study Shows COVID-19 Could Create Vulnerability to Shingles for People Age 50+

April 06, 2022

From GSK

Via Business Wire

Good and Bad stock news ↗

April 05, 2022

Microsoft is down because of an FTC investigation of its possible anti-competitive moves.

Via Talk Markets

EMA Starts Review Of Sanofi-GlaxoSmithKline's COVID-19 Vaccine ↗

March 30, 2022

Via Benzinga

Vir Soars As Its Addition To SmallCap 600 Helps Wipe Out Recent Covid Volatility ↗

March 30, 2022

Vir Biotechnology remains under pressure despite its looming addition to a new index.

Via Investor's Business Daily

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.